The Use of Biomarkers in Prostate Cancer Screening and Treatment.

about

Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects

P2860

Q57108205-A7C3C7F4-C81C-426F-AC1A-76F8D8AE7179

P2860

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

Item

http://www.wikidata.org/entity/Q52689045

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@en

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@nl

type

Item

label

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@en

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@nl

prefLabel

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@en

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@nl

P1476

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

@en

P2093

Ashley V Alford

http://www.w3.org/2001/XMLSchema#string

Ashutosh K Tewari

http://www.w3.org/2001/XMLSchema#string

Joseph M Brito

http://www.w3.org/2001/XMLSchema#string

Joseph Renzulli

http://www.w3.org/2001/XMLSchema#string

Kamlesh K Yadav

http://www.w3.org/2001/XMLSchema#string

Shalini S Yadav

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Overdiagnosis and overtreatment of prostate cancer

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation

American Cancer Society guideline for the early detection of prostate cancer: update 2010

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

Screening and prostate-cancer mortality in a randomized European study

Integrative genomic profiling of human prostate cancer

Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

P304

221-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3909/RIU0772

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29472826

http://www.w3.org/2001/XMLSchema#string

P932

5811879

http://www.w3.org/2001/XMLSchema#string

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

about

P2860

P2860

The Use of Biomarkers in Prostate Cancer Screening and Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932